Cardio Diagnostics Holdings, Inc. (CDIO) - Dilution Analysis

10-Q filing | 2.8M shares outstanding

POS AM filing: This prospectus relates to the resale from time to time by the Selling Stockholders of up to an aggregate of 41,199 shares of common stock.

10-Q filing | 1.7M shares outstanding

10-Q filing | 1.7M shares outstanding

8-K filing: Stock split 1-for-30 | Outstanding: 52,145,416 → 1,738,180

10-K filing | 52.1M shares outstanding

S-3 filing: Cardio Diagnostics Holdings, Inc. is offering up to $9,476,508 of its common stock through an at-the-market offering via Craig-Hallum Capital Group LLC.

S-1 filing: This S-1 filing is for a company offering shares of common stock by selling stockholders.

10-Q filing | 40.4M shares outstanding

POS AM filing: This POS AM filing relates to the issuance of common stock upon exercise of warrants and the resale of common stock and warrants by selling securityholders.

10-Q filing | 22.6M shares outstanding

10-Q filing | 21.1M shares outstanding

10-K filing | 21.6M shares outstanding

S-3 filing: Cardio Diagnostics Holdings, Inc. is offering shares of its common stock having a maximum aggregate offering price of up to $17.0 million from time to time through or to the Sales Agent, acting as our agent or as principal.

10-Q filing | 20.5M shares outstanding

10-Q filing | 11.8M shares outstanding

10-Q filing | 9.5M shares outstanding

POS AM filing: This is a prospectus for a secondary offering consisting of the issuance by the company of shares of common stock upon exercise of warrants and the resale of common stock and warrants by selling securityholders.

S-1 filing: This S-1 filing is for the resale of up to 20,363,637 shares of common stock by a selling securityholder.

10-K filing | 9.6M shares outstanding

S-1/A filing: This S-1/A filing relates to a secondary offering of common stock and warrants by selling securityholders and the issuance of shares upon exercise of warrants.

S-1/A filing: This S-1/A filing covers a secondary offering of 11,883,256 shares of common stock and 236,686 warrants to purchase shares of common stock, as well as the issuance of up to 3,486,686 shares of common stock upon exercise of warrants.

S-1 filing: This S-1 filing covers the primary issuance of common stock upon the exercise of warrants and resale of common stock and warrants by selling securityholders.

10-Q filing | 9.5M shares outstanding

10-Q filing | 8.1M shares outstanding

8-K filing: Mana Capital Acquisition Corp. entered into a Merger Agreement with Cardio Diagnostics, Inc., where Mana Merger Sub will merge with Cardio, and Mana Capital will change its name to Cardio Diagnostics Holdings Inc.

10-Q filing | 8.1M shares outstanding

10-K filing | 8.1M shares outstanding

8-K filing: Mana Capital Acquisition Corp. consummated its initial public offering of 6,200,000 units at $10.00 per unit, generating gross proceeds of $62,000,000, and completed a private sale of 2,500,000 warrants to Mana Capital LLC for $1.00 per warrant, generating gross proceeds of $2,500,000; the underwriters purchased an additional 300,000 option units pursuant to the partial exercise of the over-allotment option at $10.00 per unit, generating additional gross proceeds of $3,000,000; the Company issued the Sponsor a total of 75,000 shares of Common Stock in connection with the partial exercise by the underwriters of the Over-Allotment Option. ($67.5M proceeds)

8-K filing: Mana Capital Acquisition Corp. consummated its initial public offering of 6,200,000 units at $10.00 per Unit, generating gross proceeds of $62,000,000, and completed a private sale of 2,500,000 warrants to Mana Capital LLC for $1.00 per warrant, generating gross proceeds of $2,500,000. Additionally, the underwriters purchased 300,000 option units at $10.00 per unit for $3,000,000 in gross proceeds. The Company also issued 75,000 shares of Common Stock to the Sponsor. ($67.5M proceeds)

8-K filing: Mana Capital Acquisition Corp. consummated its IPO of 6,200,000 units at $10.00 per unit, generating gross proceeds of $62,000,000, and simultaneously completed a private sale of 2,500,000 warrants to the Sponsor at $1.00 per warrant, generating gross proceeds of $2,500,000. ($64.5M proceeds)

S-1/A filing: Initial public offering of 6,200,000 units at $10.00 per unit, each unit consisting of one share of common stock, one-half of one redeemable warrant, and one right to receive one-seventh (1/7) of a share of common stock upon the consummation of an initial business combination.

S-1/A filing: Initial public offering of 6,200,000 units at $10.00 per unit, each unit consists of one share of common stock, par value $0.00001, and one-half of one redeemable warrant and one right to receive one-seventh (1/7) of a share of common stock upon the consummation of an initial business combination. Concurrent private placement of 2,500,000 warrants to the sponsor at $1.00 per warrant with an exercise price of $11.50 per share.

S-1 filing: Mana Capital Acquisition Corp. is offering 6,000,000 units at $10.00 per unit, with each unit consisting of one share of common stock, one-half of one redeemable warrant, and one right to receive one-seventh (1/7) of a share of common stock upon the consummation of an initial business combination.